The global bioinformatics market was valued at USD 10.1 billion in 2022 and is projected to experience substantial growth, with an estimated compound annual growth rate (CAGR) of 13.7% from 2023 to 2030. The primary factors driving this market's expansion include increasing demand for bioinformatics tools in novel drug research and development (R&D), as well as rising investments from both private and public funding sources aimed at supporting research activities.

One of the key drivers of growth in the bioinformatics market is the increasing emphasis on drug discovery and the development of new therapeutics. Bioinformatics tools and software play a crucial role in advancing the drug development process, offering efficient ways to analyze biomarkers and identify potential drug targets. Additionally, these tools are integral in the early stages of drug discovery, particularly in the detection of toxicity—a critical aspect of ensuring the safety and efficacy of new drugs. The adoption of bioinformatics solutions for these purposes is expected to continue to grow, supporting the industry's growth over the forecast period.

With the continuous advancement of technologies in genomics, proteomics, and other -omics fields, the demand for bioinformatics solutions is expected to grow. Increased R&D initiatives and the need for improved data management and analysis solutions will continue to drive bioinformatics market growth. As the volume of biological data increases, the market will require more advanced software and analytical platforms capable of handling these large datasets efficiently.

The market is also likely to benefit from ongoing developments in bioinformatics, as research organizations and pharmaceutical companies push forward in efforts to streamline drug discovery, improve clinical trial processes, and enhance personalized medicine. These advancements will further accelerate the demand for bioinformatics solutions, fueling the market's growth over the coming years.

Gather more insights about the market drivers, restrains and growth of the Bioinformatics Market

Regional Insights

North America

North America led the global bioinformatics market in 2022, capturing a significant 43.6% of the market revenue. The primary contributors to this dominant market share are the United States and Canada, which host numerous prestigious research organizations, universities, and bioinformatics companies. These institutions are at the forefront of driving innovation in molecular biology, genome sequencing, and bioinformatics technologies. The region’s strong investment in research and development (R&D), particularly in emerging areas like genomic research and precision medicine, is expected to further propel the market.

A key example of this development is the launch of a bioinformatics platform by LatchBio, a biotechnology startup based in California. The platform, introduced in June 2022, is designed to handle large biotech datasets, enhancing the ability to accelerate scientific discovery and supporting genomics research. This growth in R&D, coupled with strong industry infrastructure, is expected to maintain North America's leadership in the bioinformatics market throughout the forecast period.

In addition to molecular biology and genome sequencing, the region’s demand for bioinformatics solutions is supported by the growing application of these technologies across a variety of sectors, including pharmaceuticals, healthcare, agriculture, and environmental studies. As technological advancements continue, the region is well-positioned to sustain its growth and further innovate in the bioinformatics space.

Asia Pacific

Asia Pacific is set to emerge as the fastest-growing market, with a projected CAGR of 18.4% from 2023 to 2030. Several factors contribute to the rapid expansion of the bioinformatics industry in this region, including a highly skilled workforce, growing investments in the IT sector, and an increasing demand for bioinformatics outsourcing services. Many countries in the Asia Pacific region are also significantly improving their capabilities to handle bioinformatics data analysis, making them key players in the global market.

Government policies in the region play a pivotal role in accelerating bioinformatics growth. For example, China has initiated programs such as the China Precision Medicine Initiative and the China National GeneBank, both of which aim to enhance genomic research and apply bioinformatics to improve healthcare outcomes. These initiatives underscore the region’s commitment to advancing bioinformatics and using it to make strides in areas like personalized medicine and public health. Additionally, countries like India and South Korea are also strengthening their bioinformatics infrastructure by promoting innovation and investing in education and technology. These supportive government programs are expected to boost bioinformatics adoption across the region.

As Asia Pacific’s IT and healthcare industries continue to grow, the demand for bioinformatics tools and platforms is expected to surge. These regions, particularly China, India, and South Korea, are anticipated to become significant hubs for bioinformatics outsourcing, providing services and solutions to developed economies. The combination of highly trained bioinformaticians, strong government backing, and an expanding biotech ecosystem is set to propel the region to the forefront of the global bioinformatics market.

Browse through Grand View Research's  Biotechnology Industry Research Reports.

• The global proteomics market size was estimated at USD 24.29 billion in 2023 and is projected to grow at a CAGR of 13.10% from 2024 to 2030. 

• The global genomics market size was valued at USD 32.65 billion in 2023 and is projected to witness a compound annual growth rate (CAGR) of 16.5% from 2024 to 2030.

Key Companies & Market Share Insights

Leading players in the bioinformatics market are heavily focused on advancing genetic and proteomic sequencing technologies to enhance the capabilities of DNA and RNA sequencing. The development of next-generation sequencing (NGS) technologies is a major growth driver for the bioinformatics industry, as these advancements promise to reduce the costs and improve the efficiency of genome sequencing.

For instance, in March 2021, Agilent Technologies Inc. launched the SureSelect system, a highly customizable and robust platform designed for the analysis of the human exome. This technology helps to refine and streamline sequencing processes, enabling more accurate and cost-effective analysis in genomics research.

Similarly, in January 2020, Charles River Laboratories Inc. entered into a collaboration with Fios Genomics, gaining access to the latter’s expertise in bioinformatics and biology. This partnership enables Charles River to enhance its capabilities in genetic research and expand its service offerings in bioinformatics, further strengthening its position in the growing market.

In another significant development, Illumina, a global leader in genomic technology, announced the launch of a cloud-based bioinformatics platform in January 2021. This platform is designed to streamline data analysis in genomics and has been integrated with the Pan-Cancer IVD Test to enhance the detection and monitoring of cancer. By combining bioinformatics with cutting-edge technologies, Illumina aims to revolutionize cancer detection and support the ongoing efforts in personalized medicine.

Key Bioinformatics Companies

Following are some of the major players in the global bioinformatics market:

• DNAnexus Inc.

• Seven Bridges Genomics

• BGI Group

• Partek Inc.

• Thermo Fisher Scientific

• Qiagen

• Agilent Technologies

• Illumina

• PerkinElmer

Order a free sample PDF of the Bioinformatics Market Intelligence Study, published by Grand View Research.